Total Clarity Wealth Management Inc. Buys Shares of 10,479 Tempus AI, Inc. $TEM

Total Clarity Wealth Management Inc. bought a new stake in Tempus AI, Inc. (NASDAQ:TEM) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 10,479 shares of the company’s stock, valued at approximately $666,000.

Several other hedge funds have also recently made changes to their positions in the company. ARK Investment Management LLC raised its stake in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after buying an additional 1,981,755 shares during the period. Vanguard Group Inc. raised its stake in shares of Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock valued at $289,204,000 after purchasing an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. raised its stake in shares of Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after purchasing an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the period. Finally, CloudAlpha Capital Management Limited Hong Kong bought a new stake in shares of Tempus AI during the 1st quarter valued at $34,119,000. 24.22% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on TEM shares. Piper Sandler reiterated a “neutral” rating on shares of Tempus AI in a research note on Friday, August 8th. HC Wainwright boosted their price objective on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research note on Friday, September 12th. Needham & Company LLC restated a “buy” rating and set a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th. BTIG Research boosted their target price on Tempus AI from $75.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday, August 20th. Finally, Bank of America boosted their target price on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 25th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $71.83.

Tempus AI Price Performance

TEM opened at $96.39 on Monday. The stock has a 50-day moving average price of $78.89 and a 200-day moving average price of $64.87. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $104.32. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The stock has a market capitalization of $16.75 billion, a P/E ratio of -81.00 and a beta of 4.87.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million during the quarter, compared to analysts’ expectations of $296.84 million. During the same period in the prior year, the business earned ($6.86) EPS. The company’s revenue for the quarter was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Activity at Tempus AI

In related news, CFO James William Rogers sold 7,528 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the completion of the sale, the chief financial officer directly owned 138,473 shares in the company, valued at $10,337,009.45. This represents a 5.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Ryan Fukushima sold 5,000 shares of the stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $92.32, for a total value of $461,600.00. Following the sale, the chief operating officer owned 130,000 shares of the company’s stock, valued at $12,001,600. This represents a 3.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 933,662 shares of company stock worth $68,070,993 over the last three months. Corporate insiders own 26.27% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.